MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 215 filers reported holding MIRATI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,771 | +14.0% | 385 | -5.4% | 0.00% | – |
| Q2 2023 | $14,705 | -11.9% | 407 | -9.4% | 0.00% | – |
| Q1 2023 | $16,694 | -19.7% | 449 | -2.2% | 0.00% | – |
| Q4 2022 | $20,797 | -32.9% | 459 | +1.8% | 0.00% | – |
| Q3 2022 | $31,000 | +3.3% | 451 | +0.2% | 0.00% | – |
| Q2 2022 | $30,000 | -50.8% | 450 | -38.9% | 0.00% | – |
| Q1 2022 | $61,000 | -43.5% | 736 | -0.3% | 0.00% | -100.0% |
| Q4 2021 | $108,000 | -15.0% | 738 | +3.1% | 0.00% | 0.0% |
| Q3 2021 | $127,000 | +1.6% | 716 | -7.4% | 0.00% | – |
| Q2 2021 | $125,000 | -97.2% | 773 | -97.1% | 0.00% | -100.0% |
| Q1 2021 | $4,495,000 | -22.3% | 26,241 | -0.4% | 0.02% | -23.8% |
| Q4 2020 | $5,787,000 | +55.3% | 26,347 | +17.4% | 0.02% | +16.7% |
| Q3 2020 | $3,726,000 | +45.1% | 22,438 | -0.2% | 0.02% | +50.0% |
| Q2 2020 | $2,567,000 | +89.7% | 22,484 | +27.7% | 0.01% | +71.4% |
| Q1 2020 | $1,353,000 | -38.4% | 17,605 | +3.2% | 0.01% | -12.5% |
| Q4 2019 | $2,198,000 | +64.0% | 17,056 | -0.8% | 0.01% | +60.0% |
| Q3 2019 | $1,340,000 | -18.1% | 17,200 | +8.3% | 0.01% | -16.7% |
| Q2 2019 | $1,636,000 | +63.3% | 15,887 | +16.3% | 0.01% | +50.0% |
| Q1 2019 | $1,002,000 | +78.0% | 13,664 | +2.9% | 0.00% | +100.0% |
| Q4 2018 | $563,000 | -10.6% | 13,281 | -0.7% | 0.00% | 0.0% |
| Q3 2018 | $630,000 | +8.2% | 13,381 | +13.4% | 0.00% | 0.0% |
| Q2 2018 | $582,000 | +1319.5% | 11,799 | +48.8% | 0.00% | – |
| Q1 2017 | $41,000 | +17.1% | 7,928 | +8.6% | 0.00% | – |
| Q4 2016 | $35,000 | -99.9% | 7,299 | -0.3% | 0.00% | – |
| Q3 2016 | $48,379,000 | +21.2% | 7,319 | +0.2% | 0.00% | – |
| Q2 2016 | $39,902,000 | -72.7% | 7,308 | +7.0% | 0.00% | -100.0% |
| Q1 2016 | $146,000,000 | -32.4% | 6,832 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $216,000,000 | +107362.7% | 6,832 | +16.9% | 0.00% | 0.0% |
| Q3 2015 | $201,000 | -99.9% | 5,842 | +0.1% | 0.00% | 0.0% |
| Q2 2015 | $183,659,000 | +38.9% | 5,836 | +29.4% | 0.00% | 0.0% |
| Q1 2015 | $132,263,000 | +58.3% | 4,511 | 0.0% | 0.00% | – |
| Q4 2014 | $83,544,000 | +1.7% | 4,511 | -3.8% | 0.00% | – |
| Q3 2014 | $82,122,000 | -12.5% | 4,690 | -0.1% | 0.00% | – |
| Q2 2014 | $93,860,000 | – | 4,693 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $116,595,216 | 81.37% |
| ORACLE INVESTMENT MANAGEMENT INC | 201,400 | $7,488,052 | 7.25% |
| Paradigm Biocapital Advisors LP | 1,396,779 | $51,932,243 | 4.92% |
| Octagon Capital Advisors LP | 750,000 | $27,885,000 | 4.01% |
| Boxer Capital, LLC | 2,000,000 | $74,360 | 3.65% |
| Artal Group S.A. | 1,537,709 | $57,172 | 3.40% |
| Avoro Capital Advisors LLC | 5,555,555 | $206,555,535 | 3.06% |
| RTW INVESTMENTS, LP | 3,643,114 | $135,450,979 | 2.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 244,000 | $9,071,920 | 2.53% |
| Kynam Capital Management, LP | 499,853 | $18,584,535 | 2.40% |